ADMA BIOLOGICS INC (ADMA)
US0008991046 - Common Stock
ADMA BIOLOGICS INC
NASDAQ:ADMA (10/21/2024, 3:27:50 PM)
15.54
-0.24 (-1.52%)
Company Profile
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The company is headquartered in Ramsey, New Jersey and currently employs 624 full-time employees. The company went IPO on 2013-10-17. The firm manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV (immune globulin intravenous, human - slra 10% liquid) for the treatment of PI, and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.
Company Info
ADMA BIOLOGICS INC
C/O Adma Biologics, Inc., 465 State Route 17
Ramsey NEW JERSEY 07446
P: 12014785552
CEO: Adam S. Grossman
Employees: 624
Website: https://www.admabiologics.com/
ADMA News
4 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors...
5 days ago - Bronstein, Gewirtz & Grossman, LLCADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm/PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADMA Biologics Inc ("ADMA Biologics" or "the...
6 days ago - Bragar Eagel & SquireADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm7 days ago - Investor's Business DailyAmphastar Casts Wide Net, Hauls In Profits, Gets Rating UpgradeAmphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January.
8 days ago - Investor's Business DailyAlkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty ProfitsAlkermes develops treatments for neurodegenerative diseases (conditions that damage and destroy parts of the nervous system) and cancer.
11 days ago - Investor's Business DailyIBD 50's Top Stock, ADMA Biologics, Crashes After Auditor Unexpectedly ResignsThe company reiterated its outlook for 2024 and 2025.
ADMA Twits
Here you can normally see the latest stock twits on ADMA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
